Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial. [electronic resource]
- International urology and nephrology May 2014
- 927-33 p. digital